Free Trial
LON:OVB

Ovoca Bio (OVB) Share Price, News & Analysis

GBX 1.15 0.00 (0.00%)
As of 05/7/2025

About Ovoca Bio Stock (LON:OVB)

Key Stats

Today's Range
1.15
1.15
50-Day Range
1.05
1.39
52-Week Range
0.65
1.98
Volume
N/A
Average Volume
128,595 shs
Market Capitalization
£1.16 million
P/E Ratio
N/A
Dividend Yield
0.83%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ovoca Bio is a clinical-stage biopharmaceutical company focused on women’s health. Founded and incorporated in Ireland, the business currently operates in Ireland, the UK and Russia. Ovoca Bio is currently developing BP-101, a novel medicinal treatment for premenopausal women suffering from hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack or loss of sexual desire affecting an estimated ~4 million women in the US with similar prevalence in other countries globally. The condition represents a significant area of high unmet medical need with few and challenging treatment options.

Receive OVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ovoca Bio and its competitors with MarketBeat's FREE daily newsletter.

OVB Stock News Headlines

Ovoca Bio plc (OVB.L)
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
OVB.I - Ovoca Bio PLC Profile | Reuters
See More Headlines

OVB Stock Analysis - Frequently Asked Questions

Ovoca Bio's stock was trading at GBX 1.60 at the start of the year. Since then, OVB shares have decreased by 28.1% and is now trading at GBX 1.15.
View the best growth stocks for 2025 here
.

Shares of OVB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ovoca Bio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and J D Wetherspoon (JDW).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:OVB
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.35 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 1.16 per share
Price / Cash Flow
1.00
Book Value
GBX 2.41 per share
Price / Book
0.48

Miscellaneous

Free Float
N/A
Market Cap
£1.16 million
Optionable
Not Optionable
Beta
0.90
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:OVB) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners